S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843344.19780.98 |
| _version_ | 1827332542463737856 |
|---|---|
| author | S. Rives S. L. Maude H. Hiramatsu A. Baruchel P. Bader H. Bittencourt J. Buechner T. Laetsch B. De Moerloose M. Qayed H. E. Stefanski K. L. Davis P. L. Martin E. Nemecek C. Peters G. Yanik A. Balduzzi N. Boissel S. L. Khaw J. Krueger J. Levine S. Davies G. D. Myers A. Yeo D. O’Donovan R. Ramos M. Pulsipher S. Grupp |
| author_facet | S. Rives S. L. Maude H. Hiramatsu A. Baruchel P. Bader H. Bittencourt J. Buechner T. Laetsch B. De Moerloose M. Qayed H. E. Stefanski K. L. Davis P. L. Martin E. Nemecek C. Peters G. Yanik A. Balduzzi N. Boissel S. L. Khaw J. Krueger J. Levine S. Davies G. D. Myers A. Yeo D. O’Donovan R. Ramos M. Pulsipher S. Grupp |
| author_sort | S. Rives |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:01:32Z |
| format | Article |
| id | doaj.art-00796bb2d52f43dbb8927665257541ae |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:01:32Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-00796bb2d52f43dbb8927665257541ae2024-03-03T03:19:23ZengWileyHemaSphere2572-92412022-06-016131410.1097/01.HS9.0000843344.19780.98202206003-00013S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDYS. Rives0S. L. Maude1H. Hiramatsu2A. Baruchel3P. Bader4H. Bittencourt5J. Buechner6T. Laetsch7B. De Moerloose8M. Qayed9H. E. Stefanski10K. L. Davis11P. L. Martin12E. Nemecek13C. Peters14G. Yanik15A. Balduzzi16N. Boissel17S. L. Khaw18J. Krueger19J. Levine20S. Davies21G. D. Myers22A. Yeo23D. O’Donovan24R. Ramos25M. Pulsipher26S. Grupp271 Department of Pediatric Hematology – Oncology, Hospital Sant Joan de Déu Barcelona, and Institut de Recerca Sant Joan de Déu, Barcelona, Spain2 Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children’s Hospital of Philadelphia and Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America3 Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan4 University Hospital Robert Debré (APHP) and Université de Paris, Paris, France5 Division of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany6 Department of Pediatrics, Faculty of Medicine, University of Montreal, and the Hematology Oncology Division and Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Centre, Montreal, QC, Canada7 Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway2 Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children’s Hospital of Philadelphia and Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America8 Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium9 Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA10 National Bone Marrow Donor Program, Be the Match, Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis, MN11 Division of Hematology, Oncology and Stem Cell Transplant, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA12 Pediatric Transplant and Cellular Therapy, Duke University Medical Center, Durham, NC13 Oregon Health and Science University, Portland, OR, United States of America14 Stem Cell Transplantation Unit, St. Anna Children’s Hospital, Vienna, Austria15 Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI, United States of America16 Clinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione MBBM, Ospedale San Gerardo, Monza, Italy17 Saint-Louis Hospital (APHP) and Université de Paris, Paris, France18 Children’s Cancer Centre, Royal Children’s Hospital and Murdoch Children’s Research Institute, Parkville, VIC, Australia19 Division of Haematology/Oncology/Bone Marrow Transplantation, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada20 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY21 Cincinnati Children’s Hospital Medical Center, Cincinnati, OH22 Children’s Mercy Hospital and Clinics, Kansas City, MO23 Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States of America24 Novartis Pharmaceuticals Corporation, Dublin, Ireland23 Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States of America25 Division of Pediatric Hematology and Oncology, Intermountain Primary Children’s Hospital, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, United States of America2 Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children’s Hospital of Philadelphia and Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000843344.19780.98 |
| spellingShingle | S. Rives S. L. Maude H. Hiramatsu A. Baruchel P. Bader H. Bittencourt J. Buechner T. Laetsch B. De Moerloose M. Qayed H. E. Stefanski K. L. Davis P. L. Martin E. Nemecek C. Peters G. Yanik A. Balduzzi N. Boissel S. L. Khaw J. Krueger J. Levine S. Davies G. D. Myers A. Yeo D. O’Donovan R. Ramos M. Pulsipher S. Grupp S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY HemaSphere |
| title | S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY |
| title_full | S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY |
| title_fullStr | S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY |
| title_full_unstemmed | S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY |
| title_short | S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY |
| title_sort | s112 tisagenlecleucel in pediatric and young adult patients pts with relapsed refractory r r b cell acute lymphoblastic leukemia b all final analyses from the eliana study |
| url | http://journals.lww.com/10.1097/01.HS9.0000843344.19780.98 |
| work_keys_str_mv | AT srives s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT slmaude s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT hhiramatsu s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT abaruchel s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT pbader s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT hbittencourt s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT jbuechner s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT tlaetsch s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT bdemoerloose s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT mqayed s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT hestefanski s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT kldavis s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT plmartin s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT enemecek s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT cpeters s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT gyanik s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT abalduzzi s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT nboissel s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT slkhaw s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT jkrueger s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT jlevine s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT sdavies s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT gdmyers s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT ayeo s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT dodonovan s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT rramos s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT mpulsipher s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy AT sgrupp s112tisagenlecleucelinpediatricandyoungadultpatientsptswithrelapsedrefractoryrrbcellacutelymphoblasticleukemiaballfinalanalysesfromtheelianastudy |